Today, Medicine by Design and The CCRM Foundation announce that The CCRM Foundation will be the top event sponsor of the Medicine by Design 9th Annual Symposium, to be held on December 9, 2024.
“Medicine by Design and The CCRM Foundation are aligned in our mission to advance regenerative medicine therapies for diseases like heart failure, type 1 diabetes and neurodegenerative disease,” says Allison Brown, executive director, Medicine by Design.
This year’s symposium will be themed “Driving translation with transformative science,” and will focus on telling strong translational stories, starting with leading-edge science and enabling technologies through to commercialization and patient impact.
The CCRM Foundation is tackling the rising burden of chronic diseases and an aging population. By collaborating with globally leading experts and partners, The CCRM Foundation is using strategic philanthropy to support the advancement of academic-led innovations through critical, but underfunded, stages of development to catalyze life-changing cell and gene medicines that have the potential to be curative. Its mission is to improve the quality of life for patients and usher in the future of medicine.
“We’re thrilled to be introducing The CCRM Foundation to the regenerative medicine community in Toronto through our support of the Medicine by Design symposium,” says Michael May, president and CEO, CCRM. “This sponsorship is an important way to support and engage Toronto’s world-leading research community. The CCRM Foundation is leveraging the sustainability, track record and expertise of [CCRM and] global ecosystem partners to raise new funding that will be deployed back into high-impact initiatives, including Medicine by Design.”
A sponsorship highlight will be a reception, which will bring researchers, industry professionals and other stakeholders together, hosted by The CCRM Foundation after the symposium. In addition, the sponsorship will include a CCRM Therapeutic Translation Award for the trainee poster session.
Medicine by Design is a strategic hub where scientists, engineers and clinicians from the University of Toronto and its affiliated hospitals converge to conceive and translate regenerative medicine approaches to transform human health. CCRM and Medicine by Design are strategic partners.
As Medicine by Design’s annual flagship event, the symposium will showcase some of the most innovative regenerative medicine work in Canada and internationally. It will take place in the heart of Toronto’s vibrant life sciences district.
More than a dozen local and international regenerative medicine leaders will present their research at the symposium. More than 500 individuals from the regenerative medicine ecosystem in Toronto typically attend the symposium.
For more information about the 9th Annual Medicine by Design Symposium, visit https://mbd.utoronto.ca/medicine-by-design-symposium/.
About The CCRM Foundation
The CCRM Foundation is a not-for-profit corporation incorporated under the Canada Not-for-profit Corporations Act and a Canadian registered charity. The CCRM Foundation is focused on advancing education, conducting research and promoting health in the field of advanced therapies (regenerative medicine and cell and gene therapies). The CCRM Foundation seeks philanthropic support from individuals, corporations and foundations to enable its activities. It will work closely with the Centre for Commercialization of Regenerative Medicine (CCRM), a not-for-profit organization based in Toronto, Canada, and institutional, academic and other not-for-profits to identify and implement innovative opportunities through critical, but underfunded, stages of development. The CCRM Foundation will maintain the highest standards of transparency and practices.
About Medicine by Design
Founded by a $114-million grant from the Canada First Research Excellence Fund, Medicine by Design brings together researchers at the University of Toronto and its affiliated hospitals to advance regenerative medicine discoveries and accelerate them toward impact. It builds on decades of made-in-Canada excellence in regenerative medicine dating back to the discovery of stem cells in the early 1960s by Toronto researchers James Till and Dr. Ernest McCulloch.
MEDIA CONTACT:
Stacey Johnson
Vice President, Communications and Marketing
CCRM
stacey.johnson@ccrm.ca
647-309-1830